# Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction

> **NCT00502528** · PHASE2 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 57 (actual)

## Conditions studied

- ST-Elevation Myocardial Infarction

## Interventions

- **DRUG:** Placebo
- **DRUG:** BQ-123

## Key facts

- **NCT ID:** NCT00502528
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2009-08
- **Final completion:** 2012-08
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2013-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00502528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00502528, "Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00502528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*